Skip to the page

Data / Form D filings / Conceivable Life Sciences Inc.

Conceivable Life Sciences Inc.: Form D filings

Conceivable Life Sciences Inc., a health care company in New York, NY, filed 4 Form D notices with the SEC between 2023 and 2025. The latest, on September 15, 2025, reports $30.5 million sold of a $33 million offering to 20 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
160 MERCER STREET, 3RD FLOOR, New York, NY, 10012
Phone
(917) 657-2175
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2022
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1986248

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 15, 2025New notice$33,000,000$30,499,997$2,500,00320Aug 5, 2025sec.gov
Jan 2, 2025Amendment$18,000,000$15,997,162$2,002,83818Nov 22, 2024sec.gov
Dec 17, 2024New notice$18,000,000$15,097,162$2,902,83817Nov 22, 2024sec.gov
Jul 20, 2023New notice$20,000,000$16,975,000$3,025,00011Jul 7, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Alex ChristDirector
Alejandro Chavez-BadiolaExecutive Officer, Director
Stuart PetersonDirector
Aike HoDirector
Fred DestinDirector
Alan MurrayExecutive Officer, Director

Other health care companies in New York that filed recently

Every Form D from the week of Sep 15, 2025 · All recent filings in New York · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Conceivable Life Sciences Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.